journal article·2015-10

In vivo degradation behavior and biological activity of some new Mg–Ca alloys with concentration's gradient of Si for bone grafts

Lucia Carmen Trincă, Mircea Fântânariu, Carmen Solcan, Alina Elena Trofin, Liviu Burtan, Dumitru Mihai Acatrinei, Sergiu Stanciu, Bogdan Istrate, Corneliu Munteanu

Publisher page

Abstract

Abstract Magnesium based alloys, especially Mg–Ca alloys, are biocompatible substrates with mechanical properties similar to those of bones. The biodegradable alloys of Mg–Ca provide sufficient mechanical strength in load carrying applications as opposed to biopolymers and also they avoid stress shielding and secondary surgery inherent with permanent metallic implant materials. The main issue facing a biodegradable Mg–Ca alloy is the fast degradation in the aggressive physiological environment of the body. The alloy's corrosion is proportional with the dissolution of the Mg in the body: the reaction with the water generates magnesium hydroxide and hydrogen. The accelerated corrosion will lead to early loss of the alloy's mechanical integrity. The degradation rate of an alloy can be improved mainly through tailoring the composition and by carrying out surface treatments. This research focuses on the ability to adjust degradation rate of Mg–Ca alloys by an original method and studies the biological activity of the resulted specimens. A new Mg–Ca alloy, with a Si gradient concentration from the surface to the interior of the material, was obtained. The surface morphology was investigated using scanning electron microscopy (VegaTescan LMH II, SE detector, 30 kV), X-ray diffraction (X’Pert equipment) and energy dispersive X-ray (Bruker EDS equipment). In vivo degradation behavior, biological compatibility and activity of Mg–Ca alloys with/without Si gradient concentration were studied with an implant model (subcutaneous and bony) in rats. The organism response to implants was characterized by using radiological (plain X-rays and computed tomography), biochemical and histological methods of investigation. The results sustained that Si gradient concentration can be used to control the rate of degradation of the Mg–Ca alloys for enhancing their biologic activity in order to facilitate bone tissue repair.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Aluminum Alloys Composites Properties · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Biodegradable orthopedic magnesium–calcium (MgCa) alloys, processing, and corrosion performance10.3390/ma5010135 ↗
2. Calcium orthophosphate coating on magnesium and its biodegradable alloys10.1016/j.actbio.2014.02.026 ↗
3. In vitro and in vivo corrosion measurements of magnesium alloys10.1016/j.biomaterials.2005.07.037 ↗
4. Metallic scaffolds for bone regeneration10.3390/ma2030790 ↗
5. Control of biodegradation of magnesium alloys for medical applications
6. Biomedical coatings on magnesium alloys – a review10.1016/j.actbio.2012.04.012 ↗
7. Revolutionizing orthopaedic biomaterials. The potential of biodegradable and bioresorbable magnesium-based materials for functional tissue engineering10.1016/j.jbiomech.2013.12.003 ↗
8. Scaffold design for bone regeneration10.1166/jnn.2014.9127 ↗
9. ISO 10993-2:2006/(R) · 2010
10. A standardized critical size defect model in normal and osteoporotic rats to evaluate bone tissue engineered constructs10.1155/2014/348635 ↗
11. Chemistry studies
12. Kiernan · 2008
13. Clinical chemistry reference database for Wistar rats and C57/BL6 mice10.1515/BC.2007.061 ↗
14. Giknis · 2008
15. Reference intervals: the way forward10.1258/acb.2008.008170 ↗
16. Biochemical markers of bone metabolism in animals: Uses and limitations10.1111/j.1939-165X.2003.tb00323.x ↗
17. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
18. In vitro corrosion and biocompatibility of binary magnesium alloys10.1016/j.biomaterials.2008.10.021 ↗
19. In vivo degradation and tissue compatibility of ZK60 magnesium alloy with micro-arc oxidation coating in a transcortical model10.1016/j.msec.2013.05.023 ↗
20. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
21. Loss of mechanical properties in vivo and bone–implant interface strength of AZ31B magnesium alloy screws with Si-containing coating10.1016/j.actbio.2013.12.020 ↗
22. Magnesium alloys as a biomaterial for degradable craniofacial screws10.1016/j.actbio.2013.12.040 ↗
23. The regulation and function of phosphate in the human body10.1002/biof.552210167 ↗
24. Cell-induced response by tetracyclines on human bone marrow colonized hydroxyapatite and Bonelike10.1016/j.actbio.2007.12.006 ↗
25. Physiology of bone formation, remodeling, and metabolism
26. Biological basis of bone formation, remodeling, and repair – Part I: biochemical signaling molecules10.1089/ten.teb.2008.0082 ↗
27. Silicon substitution in the calcium phosphate bioceramics10.1016/j.biomaterials.2007.05.003 ↗
28. The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals10.1007/s00018-010-0527-z ↗
29. Correlation of serum alkaline phosphatase activity with the healing process of long bone fractures in dogs10.1111/j.1939-165X.2005.tb00006.x ↗
30. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage10.1177/002215540205000305 ↗
31. The mechanism of mineralization and the role of alkaline phosphatase in health and disease10.1272/jnms.77.4 ↗
32. Control of smooth muscle cell proliferation by ferrous iron10.1016/j.biomaterials.2005.10.042 ↗
33. The long-term clinical relevance of calcar atrophy caused by stress shielding in total hip arthroplasty: a 10–year, prospective, randomized study10.1016/j.arth.2003.12.081 ↗
34. Structural changes in femoral bone tissue of rats after intraperitoneal administration of nickel
35. Bone regeneration performance of surface-treated porous titanium10.1016/j.biomaterials.2014.04.054 ↗
36. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model10.1016/j.bone.2007.06.025 ↗
37. Prediction of spatio-temporal bone formation in scaffold by diffusion equation10.1016/j.biomaterials.2011.05.085 ↗
38. Stimulation of bone growth following zinc incorporation into biomaterials10.1016/j.biomaterials.2014.04.101 ↗
39. Bone regeneration of rat tibial defect by zinc-tricalcium phosphate (Zn-TCP) synthesized from porous Foraminifera carbonate macrospheres10.3390/md11125148 ↗